{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T22:44:51Z","timestamp":1759099491184},"reference-count":77,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Care Clinics"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.ccc.2007.07.003","type":"journal-article","created":{"date-parts":[[2007,11,27]],"date-time":"2007-11-27T15:00:49Z","timestamp":1196175649000},"page":"709-735","source":"Crossref","is-referenced-by-count":10,"title":["Acute Coronary Syndromes: Unstable Angina\/Non-ST Elevation Myocardial Infarction"],"prefix":"10.1016","volume":"23","author":[{"given":"Rohit","family":"Bhatheja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debabrata","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccc.2007.07.003_bib1","unstructured":"American Heart Association\/American Stroke Association-Heart Disease and Stroke Statistics. 2006."},{"key":"10.1016\/j.ccc.2007.07.003_bib2","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/0735-1097(94)90657-2","article-title":"Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture","volume":"23","author":"Fernandez-Ortiz","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ccc.2007.07.003_bib3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1161\/01.CIR.89.1.36","article-title":"Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology","volume":"89","author":"van der Wal","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.ccc.2007.07.003_bib4","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM198610163151602","article-title":"Platelet activation in unstable coronary disease","volume":"315","author":"Fitzgerald","year":"1986","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccc.2007.07.003_bib5","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1021\/bi00356a023","article-title":"Characterization of human platelet basic protein, a precursor form of low-affinity platelet factor 4 and beta-thromboglobulin","volume":"25","author":"Holt","year":"1986","journal-title":"Biochemistry"},{"key":"10.1016\/j.ccc.2007.07.003_bib6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/218137a0","article-title":"Effects of 5-hydroxytryptamine on platelet aggregation","volume":"218","author":"Baumgartner","year":"1968","journal-title":"Nature"},{"issue":"Suppl L","key":"10.1016\/j.ccc.2007.07.003_bib7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/eurheartj\/16.suppl_L.11","article-title":"The role of platelets in arterial thrombosis and the rationale for blockade of platelet GPIIb\/IIIa receptors as antithrombotic therapy","volume":"16","author":"Coller","year":"1995","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccc.2007.07.003_bib8","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S0735-1097(02)02336-7","volume":"40","author":"Braunwald","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ccc.2007.07.003_bib9","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1161\/01.CIR.80.2.410","article-title":"Unstable angina. A classification","volume":"80","author":"Braunwald","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.ccc.2007.07.003_bib10","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1161\/01.CIR.100.20.2067","article-title":"Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation","volume":"100","author":"Holmes","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ccc.2007.07.003_bib11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0735-1097(97)00160-5","article-title":"The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study. Thrombolysis in Myocardial Ischemia","volume":"30","author":"Cannon","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ccc.2007.07.003_bib12","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/0735-1097(91)90744-T","article-title":"Relation between ST segment shifts during ischemia and thrombin activity in patients with unstable angina","volume":"18","author":"Eisenberg","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ccc.2007.07.003_bib13","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/0002-9149(87)91020-4","article-title":"Outcome in suspected acute myocardial infarction with normal or minimally abnormal admission electrocardiographic findings","volume":"60","author":"Slater","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccc.2007.07.003_bib14","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1001\/jama.281.8.707","article-title":"Prognostic value of the admission electrocardiogram in acute coronary syndromes","volume":"281","author":"Savonitto","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ccc.2007.07.003_bib15","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1093\/eurheartj\/ehi395","article-title":"Extent of ST-segment depression and cardiac events in non-ST-segment elevation acute coronary syndromes","volume":"26","author":"Savonitto","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccc.2007.07.003_bib16","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0735-1097(00)00804-4","article-title":"Myocardial infarction redefined\u2014a consensus document of The Joint European Society of Cardiology\/American College of Cardiology Committee for the redefinition of myocardial infarction","volume":"36","author":"Alpert","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ccc.2007.07.003_bib17","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1161\/01.CIR.93.9.1651","article-title":"Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group","volume":"93","author":"Lindahl","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ccc.2007.07.003_bib18","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM199610313351802","article-title":"Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes","volume":"335","author":"Antman","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccc.2007.07.003_bib19","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/jama.284.7.835","article-title":"The TIMI risk score for unstable angina\/non-ST elevation MI: a method for prognostication and therapeutic decision making","volume":"284","author":"Antman","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ccc.2007.07.003_bib20","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.291.22.2727","article-title":"A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry","volume":"291","author":"Eagle","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ccc.2007.07.003_bib21","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1001\/jama.292.17.2096","article-title":"Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative","volume":"292","author":"Bhatt","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ccc.2007.07.003_bib22","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/S0735-1097(02)01770-9","article-title":"Revisiting the culprit lesion in non-Q-wave myocardial infarction. Results from the VANQWISH trial angiographic core laboratory","volume":"39","author":"Kerensky","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ccc.2007.07.003_bib23","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0140-6736(95)90865-X","article-title":"ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction","volume":"345","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.ccc.2007.07.003_bib24","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0735-1097(98)00656-1","article-title":"ACC\/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology\/American Heart Association","volume":"33","author":"Cheitlin","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ccc.2007.07.003_bib25","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1001\/jama.1988.03410150107041","article-title":"Overview of results of randomized clinical trials in heart disease. II. Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification","volume":"260","author":"Yusuf","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.ccc.2007.07.003_bib26","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(05)67661-1","article-title":"Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial","volume":"366","author":"Chen","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ccc.2007.07.003_bib27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0002-9149(00)00913-9","volume":"86","author":"Gibson","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccc.2007.07.003_bib28","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/clc.4960210906","article-title":"Verapamil use in patients with cardiovascular disease: an overview of randomized trials","volume":"21","author":"Pepine","year":"1998","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ccc.2007.07.003_bib29","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men","volume":"336","author":"Ridker","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccc.2007.07.003_bib30","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM198810273191701","article-title":"Aspirin, heparin, or both to treat acute unstable angina","volume":"319","author":"Theroux","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccc.2007.07.003_bib31","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1056\/NEJM198308183090703","article-title":"Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study","volume":"309","author":"Lewis","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccc.2007.07.003_bib32","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0140-6736(90)92336-G","article-title":"Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease","volume":"336","author":"The RISC Group","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.ccc.2007.07.003_bib33","first-page":"349","article-title":"Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2","volume":"2","author":"ISIS-2 (Second International Study of Infarct Survival) Collaborative Group","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.ccc.2007.07.003_bib34","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccc.2007.07.003_bib35","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ccc.2007.07.003_bib36","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ccc.2007.07.003_bib37","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1161\/01.CIR.0000161383.06692.D4","volume":"111","author":"Patti","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ccc.2007.07.003_bib38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/01.CIR.82.1.17","article-title":"Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial. The Studio della Ticlopidina nell'Angina Instabile Group","volume":"82","author":"Balsano","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.ccc.2007.07.003_bib39","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1161\/01.CIR.90.4.1757","article-title":"Pharmacodynamics of chimeric glycoprotein IIb\/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty","volume":"90","author":"Tcheng","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.ccc.2007.07.003_bib40","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/hj.1999.v138.a100459","article-title":"Pharmacokinetics and pharmacodynamics of glycoprotein IIb-IIIa inhibitors","volume":"138","author":"Kleiman","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.ccc.2007.07.003_bib41","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0735-1097(01)01388-2","article-title":"The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis","volume":"38","author":"Heidenreich","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ccc.2007.07.003_bib42","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJM200106213442501","article-title":"Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb\/IIIa inhibitor tirofiban","volume":"344","author":"Cannon","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccc.2007.07.003_bib43","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jacc.2005.11.012","article-title":"Randomized comparison of upstream tirofiban versus downstream high bolus dose tirofiban or abciximab on tissue-level perfusion and troponin release in high-risk acute coronary syndromes treated with percutaneous coronary interventions: the EVEREST trial","volume":"47","author":"Bolognese","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ccc.2007.07.003_bib44","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/jama.295.13.joc60034","article-title":"Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial","volume":"295","author":"Kastrati","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ccc.2007.07.003_bib45","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0735-1097(03)00514-X","article-title":"Early use of glycoprotein IIb\/IIIa inhibitors in non-ST-elevation acute myocardial infarction: observations from the National Registry of Myocardial Infarction 4","volume":"42","author":"Peterson","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ccc.2007.07.003_bib46","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0002-8703(99)70460-6","article-title":"A randomized, multicenter trial of weight-adjusted intravenous heparin dose titration and point-of-care coagulation monitoring in hospitalized patients with active thromboembolic disease. Antithrombotic Therapy Consortium Investigators","volume":"137","author":"Becker","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.ccc.2007.07.003_bib47","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jama.1996.03540100055028","article-title":"Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis","volume":"276","author":"Oler","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.ccc.2007.07.003_bib48","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1056\/NEJM199709043371007","article-title":"Low-molecular-weight heparins","volume":"337","author":"Weitz","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccc.2007.07.003_bib49","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1161\/01.CIR.92.4.962","article-title":"Role of thrombin compared with factor Xa in the procoagulant activity of whole blood clots","volume":"92","author":"Prager","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ccc.2007.07.003_bib50","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJM199708143370702","article-title":"A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group","volume":"337","author":"Cohen","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccc.2007.07.003_bib51","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0735-1097(00)00808-1","article-title":"Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE Study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q Wave Coronary Events","volume":"36","author":"Goodman","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ccc.2007.07.003_bib52","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1161\/01.CIR.100.15.1593","article-title":"Enoxaparin prevents death and cardiac ischemic events in unstable angina\/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial","volume":"100","author":"Antman","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ccc.2007.07.003_bib53","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/jama.292.1.45","article-title":"Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial","volume":"292","author":"Ferguson","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ccc.2007.07.003_bib54","doi-asserted-by":"crossref","first-page":"25E","DOI":"10.1016\/S0002-9149(97)00486-4","article-title":"Low-molecular-weight heparin (Fragmin) during instability in coronary artery disease (FRISC). FRISC Study Group","volume":"80","author":"Swahn","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccc.2007.07.003_bib55","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1053\/pcad.2002.127679","article-title":"The role of low-molecular-weight heparin in cardiovascular diseases","volume":"45","author":"Mukherjee","year":"2002","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.ccc.2007.07.003_bib56","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s11886-001-0050-9","article-title":"Bivalirudin for percutaneous coronary intervention and in acute coronary syndromes","volume":"3","author":"Bates","year":"2001","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.ccc.2007.07.003_bib57","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0140-6736(98)07332-2","article-title":"Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial","volume":"353","author":"Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ccc.2007.07.003_bib58","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa062437","article-title":"Bivalirudin for patients with acute coronary syndromes","volume":"355","author":"Stone","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccc.2007.07.003_bib59","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/jama.292.6.696","article-title":"Long-term efficacy of bivalirudin and provisional glycoprotein IIb\/IIIa blockade vs heparin and planned glycoprotein IIb\/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial","volume":"292","author":"Lincoff","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ccc.2007.07.003_bib60","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJMoa055443","article-title":"Comparison of fondaparinux and enoxaparin in acute coronary syndromes","volume":"354","author":"Yusuf","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccc.2007.07.003_bib61","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0140-6736(99)07349-3","article-title":"Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators","volume":"354","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ccc.2007.07.003_bib62","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(02)09894-X","article-title":"Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina","volume":"360","author":"Fox","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ccc.2007.07.003_bib63","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1001\/jama.288.15.1851","article-title":"Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction","volume":"288","author":"Mahoney","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ccc.2007.07.003_bib64","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/0735-1097(95)00404-1","volume":"26","author":"Anderson","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ccc.2007.07.003_bib65","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1056\/NEJM199806183382501","article-title":"Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators","volume":"338","author":"Boden","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccc.2007.07.003_bib66","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1056\/NEJMoa044259","article-title":"Early invasive versus selectively invasive management for acute coronary syndromes","volume":"353","author":"de Winter","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccc.2007.07.003_bib67","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/S0735-1097(02)02572-X","article-title":"A long-term perspective on the protective effects of an early invasive strategy in unstable coronary artery disease: two-year follow-up of the FRISC-II invasive study","volume":"40","author":"Lagerqvist","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ccc.2007.07.003_bib68","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1053\/euhj.2001.2735","article-title":"Value of first day angiography\/angioplasty in evolving Non-ST segment elevation myocardial infarction: an open multicenter randomized trial. The VINO Study","volume":"23","author":"Spacek","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccc.2007.07.003_bib69","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004815.pub2","article-title":"Early invasive versus conservative strategies for unstable angina & non-ST-elevation myocardial infarction in the stent era","volume":"3","author":"Hoenig","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ccc.2007.07.003_bib70","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/hc2901.093188","article-title":"Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease","volume":"104","author":"Schartl","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ccc.2007.07.003_bib71","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1161\/01.CIR.99.25.3227","article-title":"Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial","volume":"99","author":"Dupuis","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ccc.2007.07.003_bib72","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1001\/jama.279.20.1643","article-title":"Antiatherothrombotic properties of statins: implications for cardiovascular event reduction","volume":"279","author":"Rosenson","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.ccc.2007.07.003_bib73","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/01.CIR.103.15.1933","article-title":"Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels","volume":"103","author":"Jialal","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ccc.2007.07.003_bib74","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccc.2007.07.003_bib75","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.jacc.2005.04.064","article-title":"Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy","volume":"46","author":"Wiviott","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ccc.2007.07.003_bib76","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.292.11.1307","article-title":"Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial","volume":"292","author":"de Lemos","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ccc.2007.07.003_bib77","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1161\/01.CIR.0000112577.69066.CB","article-title":"Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes","volume":"109","author":"Mukherjee","year":"2004","journal-title":"Circulation"}],"container-title":["Critical Care Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749070407000449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749070407000449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T18:20:37Z","timestamp":1546453237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749070407000449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":77,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0749070407000449"],"URL":"https:\/\/doi.org\/10.1016\/j.ccc.2007.07.003","relation":{},"ISSN":["0749-0704"],"issn-type":[{"value":"0749-0704","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}